EUVIMEDEUVIMED entdecken
Crossref

Deregulation of SHP-2 tyrosine phosphatase by the Helicobacter pylori virulence factor CagA

Masanori Hatakeyama

The Keio Journal of Medicine · 2002 · 51 (supplement2) · 26-32

DOI: 10.2302/kjm.51.supplement2_26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Keio Journal of Medicine, 2002. Verfasst von Masanori Hatakeyama. Beteiligte Einrichtung: Division of Molecular Oncology, Institute for Genetic Medicine and Graduate School of Science Hokkaido University, Sapporo, Japan. mhata@imm.hokudai.…. Hauptthemen laut MEDLINE: Antigens, Bacterial. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Helicobacter pylori (H. pylori) is estimated to infect about half of the world population. It causes gastric diseases ranging from gastritis to cancer and has been classified as a class I carcinogen by WHO. However, little is known about the molecular mechanisms by which H. pylori induces pathogenesis. CagA is the product of the cagA gene carried among virulent H. pylori strains and is associated with severe clinical outcomes, most notably gastric carcinoma. CagA is injected from the attached H. pylori into gastric epithelial cells and undergoes tyrosine phosphorylation. We found that wild-type, but not phosphorylation-resistant CagA, is capable of inducing a growth factor-like morphological change, termed the hummingbird phenotype, in cells. Furthermore, CagA specifically binds the SH2-containing protein tyrosine phosphatase SHP-2 in a tyrosine phosphorylation-dependent manner and stimulates phosphatase activity. Disruption of the CagA-SHP-2 complex abolishes the CagA-dependent morphological change. Conversely, constitutively active SHP-2 is capable of inducing a CagA-like morphological change when it is plasma membrane-targeted. Our results show that CagA perturbs cellular functions by deregulating SHP-2 phosphatase after translocation from H. pylori into gastric epithelial cells. Given the positive regulatory roles of SHP-2 in both cell proliferation and cell movement, the CagA-SHP-2 interaction may play an important role in the oncogenic transformation that is a hallmark of cagA+ H. pylori infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, BacterialBacterial ProteinsCell DivisionDown-RegulationEpithelial CellsHelicobacter pyloriHumansIntracellular Signaling Peptides and ProteinsModels, BiologicalModels, GeneticPhenotypePhosphorylationPolymorphism, GeneticProtein Tyrosine Phosphatase, Non-Receptor Type 11Protein Tyrosine PhosphatasesSignal TransductionStomachTransfection

Substanzen

Antigens, BacterialBacterial ProteinsIntracellular Signaling Peptides and ProteinscagA protein, Helicobacter pyloriPTPN11 protein, humanProtein Tyrosine Phosphatase, Non-Receptor Type 11Protein Tyrosine Phosphatases

Autor:innen und Institutionen

  • Division of Molecular Oncology, Institute for Genetic Medicine and Graduate School of Science Hokkaido University, Sapporo, Japan. mhata@imm.hokudai.ac.jp

Zitieren

APA

Hatakeyama, M. (2002). Deregulation of SHP-2 tyrosine phosphatase by the Helicobacter pylori virulence factor CagA. The Keio Journal of Medicine, 51(supplement2), 26-32. https://doi.org/10.2302/kjm.51.supplement2_26

Vancouver

Hatakeyama M. Deregulation of SHP-2 tyrosine phosphatase by the Helicobacter pylori virulence factor CagA. The Keio Journal of Medicine. 2002;51(supplement2):26-32. doi:10.2302/kjm.51.supplement2_26

BibTeX
@article{Hatakeyama2002,
  author = {Hatakeyama, Masanori},
  title = {Deregulation of SHP-2 tyrosine phosphatase by the Helicobacter pylori virulence factor CagA},
  journal = {The Keio Journal of Medicine},
  year = {2002},
  volume = {51},
  number = {supplement2},
  pages = {26--32},
  doi = {10.2302/kjm.51.supplement2_26}
}
Kostenlos starten →